Evidence map›Paper›PMID 42492791›Full record

ArticleMolecular & cellular proteomics : MCP2026

Label-Free Targeted Proteomics Data Analysis Workflow Selection - Benchmarking AI-based and Data-Driven Approaches.

Daniel Fochtman, Łukasz Marczak, Monika Pietrowska, Joanna Polańska, Anna Wojakowska

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel FochtmanLaboratory of Mass Spectrometry, Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.
Łukasz MarczakLaboratory of Mass Spectrometry, Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.
Monika PietrowskaCenter for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Joanna PolańskaDepartment of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland.
Anna WojakowskaLaboratory of Mass Spectrometry, Institute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland. Electronic address: astasz@ibch.poznan.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As global proteomics continues to advance, the number of identifiable proteins has increased substantially. However, this does not inherently ensure optimal quantitative performance. While targeted assays using isotope-labeled peptides can be developed, label-free strategies remain an attractive and cost-efficient option for methodological validation. Yet, systematic evaluations of data analysis workflows for label-free targeted proteomics, particularly those incorporating artificial intelligence (AI)-based tools, are still limited. Therefore, this study aimed to benchmark multiple data analysis approaches for label-free targeted proteomics as a validation framework for results obtained from global analyses. Missing-data imputation (MDI) strategies, including no MDI, k-nearest neighbors, data-driven, MSstats and AI-based methods, were evaluated, alongside consolidation and testing frameworks such as mathematical summation, best-peak selection, AI-based scaling with univariate statistics, p-value integration, MSstats Tukey's median polish or linear models and multivariate testing. Data-driven MDI combined with p-value integration consistently showed the strongest performance across accuracy, precision, specificity, and false-discovery rate, outperforming all other strategies. These findings demonstrate that careful selection of data analysis workflows can yield substantially improved quantitative outcomes compared with commonly used approaches such as simple mathematical summation. Although our conclusions are based on a controlled benchmarking dataset comprising three yeast proteins spiked into a constant human background using only one targeted approach, they can be generally applied as a default workflow for biomarker validation using the label-free approach.

Indexed as

Artificial IntelligenceProteomicsBenchmarkingData AnalysisHumansSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsWorkflowSaccharomyces cerevisiae ProteinsAI-based approachesdata analysis workflow selectiondata-driven approacheslabel-free targeted proteomicsprmPASEF

Identifiers

PMID42492791
PMCPMC13520092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.